Your session is about to expire
← Back to Search
Boric Acid + Fluconazole for Vaginal Yeast Infections (THRIVE-yeast Trial)
THRIVE-yeast Trial Summary
This trial is studying two drugs commonly used to treat vaginal yeast infections to see how well they work in women with vaginal yeast infections that keep coming back.
THRIVE-yeast Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTHRIVE-yeast Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.THRIVE-yeast Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research available to those aged 85 or younger?
"According to the screening requirements, individuals aged 18-50 are eligible for enrollment in this clinical trial."
Are there any available slots in this clinical trial for volunteers?
"Patient recruitment for this medical trial is still ongoing, as evidenced by the information hosted on clinicaltrials.gov. The study was created on December 7th 2021 and last updated February 7th 2022."
To what illnesses is the Assumed First-Time Infection Cohort typically applied?
"All three conditions of candida intertrigo, skin disinfection therapy and candidiasis can be efficiently managed with the Assumed First-Time Infection Cohort."
Could I potentially be a participant in this research endeavor?
"This clinical trial seeks 105 female participants, aged 18 to 50 years old, who have been diagnosed with vaginitis monilial. To be eligible for the study, these are the required criteria."
How many participants have enrolled in this research trial?
"Yes, according to clinicaltrials.gov, this study is currently recruiting patients. This trial was initially released on December 7th 2021 and last updated on February 7th 2022. 105 subjects are needed for this single-location research project."
Share this study with friends
Copy Link
Messenger